Log in
Enquire now
‌

COLUMBUS NANOWORKS, INC. STTR Phase I Award, May 2018

A STTR Phase I contract was awarded to COLUMBUS NANOWORKS, INC. in May, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

OverviewStructured DataIssuesContributors

Contents

sbir.gov/node/1565343
Is a
SBIR/STTR Awards
SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient
‌
COLUMBUS NANOWORKS, INC.
0
Government Agency
0
Government Branch
National Institutes of Health
National Institutes of Health
0
Award Type
STTR0
Contract Number (US Government)
1R41GM126603-010
Award Phase
Phase I0
Award Amount (USD)
225,0000
Date Awarded
May 1, 2018
0
End Date
April 30, 2019
0
Abstract

Fluorescent nanodiamonds are biocompatibleinfinitely photostableand fluoresce in a variety of wavelengthsincluding the near infraredNIRregionThese characteristics suggest transformative applications in areas ranging from pure biological research to biomedical imagingwhere protein conjugated nanodiamonds could be targeted to specific tissues in living patients or even structures within individual cellsIn order to reach this potentialhoweverthe coupling of specific targeting proteins to nanodiamond surfaces must be simplified to a point where rapid nanodiamond prototyping can be carried out by personnel with little or no chemical conjugation expertiseTo address this needwe propose the development of simplekitsfor the production of novel protein conjugated fluorescent nanodiamondswhere the end user provides the recombinant targeting protein and specifies the nanodiamond core for conjugationThe kits would consist of expression plasmids for production of a tagged version of the end user s target proteinalong with nanodiamondblanksfor quick and simple conjugationThe conjugation reactions will be mediated by either a naturally split transsplicing inteinor the Sortase A enzymeEach of these enzymatic coupling reactions allow uniform and highly oriented binding of the target protein to the nanodiamond surface via either N terminalinteinor C terminalSortase Asinglepoint attachmentThusthe tagged target proteinprovided by the end user using their recombinant expression host of choiceand nanodiamond blank will allow researchers with little skill in chemical protein conjugation to rapidly generate highly customized nanodiamond prototypes for their desired applicationsIn our Phaseworkwe will develop two core enzymatic coupling technologies based on the GOS TerL split inteinfor N terminal protein attachmentand the Staphylococcus aureus Sortase A transpeptidasefor C terminal protein attachmentIn each casea short synthetic peptide will be produced and chemically coupled to the nanodiamond surface using conventional methodswhile a complimentary peptide will be genetically fused to the desired target protein using the provided expression plasmidsBoth the intein and Sortase reactions take place spontaneously under ambient conditionsallowing highly specific coupling via simple mixing of the purified target protein and nanodiamond blankTo demonstrate these methodswe will conjugate Green Fluorescent ProteinGFPandlactamase onto the surface of a suitable nanodiamondThese two wellcharacterized model proteins have been selected due to the availability of simple activity assayswhich will facilitate the characterization and optimization of the coupling chemistriesIn the case of GFPwe will use confocal microscopy to demonstrate co localization of the protein to the nanodiamond surfacewhilelactamase will allow demonstration of the target protein retaining enzymatic activity after immobilizationIn additionthe coupling of both model proteins will be quantified using a variety of conventional immunological and biochemical assay methodsThe generation of at least three successfully coupled target protein configurations will be considered a successful demonstration of the PhasegoalsIn future workwe will further develop the kit components and nanodiamond blank production processand demonstrate additional applications of the system using FRET and more complex targeting and drug delivery strategies Project Narrative We describe enzymatic processes for attaching proteins to fluorescent nanodiamonds for bioimaging applicationsEnzyme mediated ligations are simplefastefficient and require little chemical conjugation experience by the researcherThe resulting conjugates will have uniform orientations and site specific linkages to the nanodiamond surfaceThese are much needed improvements for the development of novel bioimaging agents and will enable the development of a host of tools for the diagnosis and treatment of disease

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like COLUMBUS NANOWORKS, INC. STTR Phase I Award, May 2018

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.